Search Grant Opportunities

Comprehensive High-Impact HIV Prevention Programs for Young Men of Color Who Have Sex with Men and Young Transgender Persons of Color

ID: CDC-RFA-PS22-2203 • Type: Posted

Description

Posted: Sept. 21, 2021, 12:00 a.m. EDT
The Centers for Disease Control and Prevention (CDC) announces the availability of fiscal year 2022 funds for a cooperative agreement program for community-based organizations (CBOs) to develop and implement high-impact human immunodeficiency virus (HIV) prevention programs in the following two categories: Category A: HIV prevention services for Young Men of Color Who Have Sex with Men (YMSM of color) and their partners regardless of age, gender, and race/ethnicity Category B: HIV prevention services for Young Transgender Persons of Color (YTG persons of color) and their partners regardless of age, gender, and race/ethnicity NOTE: Throughout this funding opportunity announcement, young and youth are defined as individuals between the ages of 13-34 years. CBOs are uniquely positioned to complement and extend the reach of HIV prevention efforts implemented by state and local health departments through the optimization of services across public, private, and other CBOs to achieve objectives of increased HIV diagnoses identification, referral for pre-exposure prophylaxis (PrEP) and non-occupational post-exposure prophylaxis (nPEP) services, earlier entry to HIV care, and increased consistency of care. The program purpose is to implement comprehensive high-impact HIV prevention programs to address health disparities among YMSM of color, YTG persons of color, and their partners with the goal of reducing HIV transmission and HIV-associated morbidity and mortality. This program aligns with the goals of the HIV National Strategic Plan, 2021-2025 (HIV Plan)1 and the Division of HIV Prevention (DHP) Strategic Plan 2017-20202, supporting the ambitious goals of reducing all new HIV infections by 75% by 2025 and 90% by 2030. This program also complements the Department of Health and Human Services (HHS) initiative of Ending the HIV Epidemic in the United States (EHE)3 and supports the HIV Plan health equity-related goals of addressing social determinants of health (SDH) and syndemics affecting HIV-related outcomes.
Posted: Sept. 21, 2021, 12:00 a.m. EDT
Posted: March 4, 2021, 12:00 a.m. EST
Posted: March 4, 2021, 12:00 a.m. EST
Background
The Centers for Disease Control and Prevention (CDC) is offering fiscal year 2022 funds for a cooperative agreement program for community-based organizations (CBOs) to develop and implement high-impact human immunodeficiency virus (HIV) prevention programs. The program aims to address health disparities among young men of color who have sex with men, young transgender persons of color, and their partners with the goal of reducing HIV transmission and HIV-associated morbidity and mortality. This program aligns with the goals of the HIV National Strategic Plan, 2021-2025, the Division of HIV Prevention (DHP) Strategic Plan 2017-2020, and supports the Ending the HIV Epidemic in the US (EHE) initiative.

Grant Details
The program requires CBOs to implement comprehensive high-impact HIV prevention programs that include strategies such as prioritized HIV testing, prevention services for persons regardless of HIV status, integrated syndemic screening activities, and a status neutral approach. Recipients will collaborate with CDC as well as community, local, and state partners to finalize required or recommended activities of their programs.

The program will have two phases: a development phase lasting no longer than 6 months from the start of Year 1, followed by ongoing program implementation, monitoring, and evaluation. The total period of performance funding is $55,000,000 with an average one year award amount of $350,000. The estimated award date is April 01, 2022.

Eligibility Requirements
The grant is open for competition to all applicants. Applicants must ensure that the proposed program aligns with the local or state health department’s Jurisdictional HIV Prevention Plan and use the most current local and/or state HIV epidemiologic and surveillance data to provide information requested in this section. Applicants must conduct prioritized HIV testing efforts in non-healthcare settings to identify HIV using multiple strategies and follow current CDC guidelines and recommendations for HIV testing.

Period of Performance
The project will start on April 1, 2022, with a development phase lasting no longer than 6 months from the start of Year 1 followed by ongoing program implementation until March 31, 2027.

Grant Value
$55,000,000 in total period of performance funding with an average one year award amount of $350,000.

Place of Performance
Applicants may provide services in a maximum of three service areas within their jurisdiction.
Show All

Overview

Agency
National Center for HIV, Viral Hepatitis, STD, and TB Prevention (NCHHSTP) [HHS - CDC]
Category of Funding
Health
Funding Instruments
Cooperative Agreement
Grant Program (CFDA)
93.939 - HIV Prevention Activities Non-Governmental Organization Based
Grant Category
Discretionary
Cost Sharing / Matching Requirement
False
Source
Grants.gov
On 9/21/21 National Center for HIV, Viral Hepatitis, STD, and TB Prevention posted grant opportunity CDC-RFA-PS22-2203 for Comprehensive High-Impact HIV Prevention Programs for Young Men of Color Who Have Sex with Men and Young Transgender Persons of Color with funding of $55.0 million. The grant will be issued under grant program 93.939 HIV Prevention Activities Non-Governmental Organization Based. It is expected that 30 total grants will be made.

Timing

Posted Date
Sept. 21, 2021, 12:00 a.m. EDT
Closing Date
Nov. 19, 2021, 12:00 a.m. EST Past Due
Closing Date Explanation
Electronically submitted applications must be submitted no later than 11:59 pm ET on the listed application due date.
Last Updated
Oct. 22, 2021, 2:46 p.m. EDT
Version
2
Archive Date
Nov. 23, 2021

Eligibility

Eligible Applicants
Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Info
Applicants are eligible to apply for funding under one category (Category A or B). This NOFO is seeking applications from organizations that were founded for the purpose of serving the selected priority population(s) and are rooted or embedded within the communities they serve. Applicants may provide HIV prevention services in a maximum of three (3) service areas within the applicant's jurisdiction. Applicants can provide HIV prevention services in areas that cross over into bordering state health department jurisdictions (e.g., District of Columbia, Maryland, and Virginia). The applicant must have a history of providing HIV prevention services in the applicant's jurisdiction, discussed provision of services with their state or local health department in which they report HIV diagnoses, and received written consent from state or local health department. (See Attachment C: Health Department Letter of Support/Health Department Prioritized HIV Testing and Partner Services Letter of Agreement).

Award Sizing

Ceiling
Not Listed
Floor
Not Listed
Estimated Program Funding
$55,000,000
Estimated Number of Grants
30

Contacts

Contact
Centers for Disease Control - NCHHSTP
Contact Email
egd8@cdc.gov / hqn7@cdc.gov
Contact Phone
(770) 488-2756

Documents

Posted documents for CDC-RFA-PS22-2203

Grant Awards

Grants awarded through CDC-RFA-PS22-2203

Incumbent or Similar Grants

Similar Active Opportunities

Open grant opportunities similar to CDC-RFA-PS22-2203